|Last Price$20.77||Day Change (%)0.10%|
|Open Price$20.77||Day Change ($)0.02|
|Day Range20.77–20.77||52-Week Range19.83–24.75|
As of Fri 03/24/2017 | USD
Global Epinephrine Autoinjector Market to Grow at a CAGR of 14.58%, 2017-2021 with ALK-Abell, Impax Laboratories, Lincoln Medical & Mylan Dominating - Research and Markets
Watson Pharmaceuticals WPI scored big Tuesday when the Food and Drug Administration approved the firm's generic fentanyl patch. We may modestly increase our fair value estimate for Watson and will maintain our fair value estimate for competitor Mylan Laboratories MYL . The pain patch is one of the ...
Mylan Laboratories MYL reported impressive second-quarter results Wednesday. However, most of the improvement was temporary and will not affect our fair value estimate. The quarter was only slightly better than we expected after excluding a one-time litigation payment and proceeds from a product ...
UPDATE: Why PTC Therapeutics may have to lower the price on a $89,000-a-year drug it just bought
Why PTC Therapeutics may have to lower the price on a $89,000-a-year drug it just bought
UPDATE: Trump's 'Obamacare Lite' presents opportunities and perils for investors
Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry 2017 - Research and Markets
Increasing Prevalence of Allergies to Boost the Global Epinephrine Autoinjector Market Through 2021, Reports Technavio
MARKET SNAPSHOT: Stock Markets Roar To Records After Trump Speech
UPDATE: Stock markets roar to records after Trump speech